Yogesh Baban Surase

Title: **Yogesh Baban Surase: Innovator in Pharmaceutical Research**

Introduction

Yogesh Baban Surase is an accomplished inventor based in Maharashtra, India, known for his contributions to pharmaceutical innovations. With a focus on developing effective treatments, he has patented a significant invention that positions him as a notable figure in the field of medicinal chemistry.

Latest Patents

Surase holds a patent for "6-morpholinyl-2-pyrazolyl-9H-purine derivatives and their use as PI3K inhibitors." This invention addresses the need for new therapeutic agents capable of inhibiting phosphatidylinositol-3-kinase (PI3K). The patent outlines a pyrazole derivative characterized by a specified formula and its variants, which are positioned for use in treating inflammatory, autoimmune, orphan, and hyperproliferative diseases. Alongside the active ingredient, the patent also discusses pharmaceutical compositions, production methods, and practical applications.

Career Highlights

Surase works at Daiichi Sankyo Company, Limited, a respected pharmaceutical firm known for its dedication to research and development. His role involves leveraging his expertise in medicinal chemistry to drive innovations that could lead to significant breakthroughs in drug development.

Collaborations

During his tenure at Daiichi Sankyo, Surase has worked alongside talented individuals such as Kirandeep Kaur Samby and Sagar Ramdas Amale. Their collaborative efforts enhance the innovation landscape within the company, fostering an environment that encourages groundbreaking research and development.

Conclusion

Yogesh Baban Surase exemplifies the spirit of innovation in the pharmaceutical industry. His patent for PI3K inhibitors showcases his commitment to addressing critical health issues through scientific advancement. As he continues to collaborate with his peers, Surase undoubtedly paves the way for future innovations that could transform medical treatments.